AVITA Medical, Inc. RCEL
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +353.62%
- 1 year
- +326.43%
- Open
- 16.54
- Prev close
- 16.71
- Mkt cap
- 484.01M
- Vol
- 597.05K
- Avg vol
- 482.35K
- EPS
- -1.43
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.24
- High
- 16.60
- Forward P/E
- -14.33
- Beta
- 1.54
- Short ratio
- 10.24
- Inst. own
- 23.45%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 11.87
- 200-d avg
- 10.61
- 1y target
- 16.81
5D chart
Signals (129)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:50 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:35 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:55 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 28, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 10:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 27, 4:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:40 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:30 PM | 4 days ago |
| RSI: Overbought | Oct 27, 12:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:10 PM | 4 days ago |
| RSI: Overbought | Oct 27, 11:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 11:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 4 days ago |
| RSI: Overbought | Oct 27, 11:20 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 10:55 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:50 AM | 5 days ago |
| RSI: Oversold | Oct 26, 9:40 AM | 5 days ago |
| SMA: Bearish | Oct 26, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 23, 3:55 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 3:50 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:20 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 2:45 PM | 1 week ago |
| SMA: Bearish | Oct 23, 2:40 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 2:15 PM | 1 week ago |
| RSI: Overbought | Oct 23, 2:15 PM | 1 week ago |
| SMA: Bullish | Oct 23, 2:05 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:55 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:30 PM | 1 week ago |
| SMA: Bullish | Oct 23, 10:35 AM | 1 week ago |
| SMA: Bearish | Oct 23, 10:25 AM | 1 week ago |
| SMA: Bullish | Oct 23, 10:20 AM | 1 week ago |
News
-
2 weeks ago benzinga.com
BTIG Maintains Buy on AVITA Medical, Raises Price Target to $15
BTIG analyst Ryan Zimmerman maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $11 to $15.
2 weeks ago benzinga.com
AVITA Medical Q2 2026 Earnings Call Transcript
On Thursday, AVITA Medical (NASDAQ:RCEL) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings…
-
2 months ago benzinga.com
TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $14
TD Cowen analyst Joshua Jennings maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $12 to $14.
-
2 months ago benzinga.com
BTIG Maintains Buy on AVITA Medical, Raises Price Target to $11
BTIG analyst Ryan Zimmerman maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $7 to $11.
-
2 months ago benzinga.com
AVITA Medical Announces PermeaDerm-I Study Met Primary Endpoint, Delivering Clinically Comparable Outcomes To Cadaveric Allograft With 70% Cost Reduction
Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p<0.001) 96% reduction in preparation time and…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report…
2 months ago benzinga.com
This SpaceX Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Wall Street analysts upgraded AVITA, Etsy, Unity, and raised target prices for these stocks. See what others think before buying Unity.
-
2 months ago benzinga.com
BTIG Upgrades AVITA Medical to Buy, Announces $7 Price Target
BTIG analyst Ryan Zimmerman upgrades AVITA Medical (NASDAQ:RCEL) from Neutral to Buy and announces $7 price target.
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings…
-
2 months ago benzinga.com
AVITA Medical Raises FY2026 Sales Guidance from $80.000M-$85.000M to $86.000M-$89.000M vs $82.350M Est
AVITA Medical (NASDAQ:RCEL) raises FY2026 sales outlook from $80.000 million-$85.000 million to $86.000 million-$89.000 million vs $82.350 million estimate.
-
2 months ago benzinga.com
AVITA Medical Q2 EPS $(0.25) Beats $(0.29) Estimate, Sales $21.702M Beat $20.167M Estimate
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 34.21 percent increase over losses of…
3 months ago benzinga.com
Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Celestica Inc (NYSE: CLS) exceeded analyst estimates with quarterly earnings of $2.54 per share and revenue of $4.7 billion, leading to a 4.7% jump in pre-market trading. Other top gainers include…
3 months ago benzinga.com
Why ServiceNow Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
ServiceNow Inc (NOW) rose in pre-market trading after reporting better-than-expected Q2 results. LGCL, PLAG, EHGO, ZYBT, DOMO, AEHL, HYLN, LBGJ, RYAM gained. LESL, ZCMD, WHLR fell.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics…
-
5 months ago benzinga.com
Lake Street Upgrades AVITA Medical to Buy, Raises Price Target to $6
Lake Street analyst Frank Takkinen upgrades AVITA Medical (NASDAQ:RCEL) from Hold to Buy and raises the price target from $3.5 to $6.
-
5 months ago benzinga.com
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
5 months ago benzinga.com
AVITA Medical Affirms FY2026 Sales Guidance of $80.000M-$85.000M vs $82.258M Est
AVITA Medical (NASDAQ:RCEL) affirms FY2026 sales outlook from $80.000 million-$85.000 million to $80.000 million-$85.000 million vs $82.258 million estimate.
-
5 months ago benzinga.com
AVITA Medical Q1 EPS $(0.35) Misses $(0.28) Estimate, Sales $19.251M Beat $18.175M Estimate
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 33.96 percent increase over losses of…
-
6 months ago benzinga.com
AVITA Medical Appoints Cary Vance President, CEO; Jan Stern As Board Chair, Effective Immediately
AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company, today announced that its Board of Directors has appointed Cary Vance as President and Chief Executive…
-
6 months ago benzinga.com
AVITA Medical Announces Data From Cohealyx-I Multi-Center Trial Shows Reduction Of ~20 Days In Mean Time To Skin Grafting For Participants With Full-Thickness Wounds
AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced positive interim results from its Cohealyx-I multi-center study demonstrating a…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
6 months ago benzinga.com
AVITA Medical Enters Into 10-Yr Agreement With BARDA Valued At Up To $25.5M To Strengthen National Preparedness For Burn Mass Casualty Incidents
Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access to 3,000 units any time over the 10-year contract VALENCIA, Calif., April 08, 2026 (GLOBE…
-
8 months ago benzinga.com
Northland Capital Markets Initiates Coverage On AVITA Medical with Outperform Rating, Announces Price Target of $10
Northland Capital Markets analyst Carl Byrnes initiates coverage on AVITA Medical (NASDAQ:RCEL) with a Outperform rating and announces Price Target of $10.
-
8 months ago benzinga.com
D. Boral Capital Maintains Buy on AVITA Medical, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $10 price target.
-
8 months ago benzinga.com
AVITA Medical Affirms FY2026 Sales Guidance of $80.000M-$85.000M vs $85.600M Est
AVITA Medical (NASDAQ:RCEL) affirms FY2026 sales outlook from $80.000 million-$85.000 million to $80.000 million-$85.000 million vs $85.600 million estimate.
8 months ago benzinga.com
AVITA Medical Q4 Earnings Summary & Key Takeaways
AVITA Medical Q4 Earnings Summary & Key Takeaways
-
8 months ago benzinga.com
AVITA Medical Q4 EPS $(0.38) Misses $(0.36) Estimate, Sales $17.616M Miss $17.838M Estimate
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.36) by 4.4 percent. This is a 13.64 percent increase over losses of…
-
8 months ago benzinga.com
Earnings Scheduled For February 12, 2026
Earnings Scheduled For February 12, 2026
-
9 months ago benzinga.com
D. Boral Capital Maintains Buy on AVITA Medical, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $10 price target.
-
9 months ago benzinga.com
Lake Street Maintains Hold on AVITA Medical, Raises Price Target to $3.5
Lake Street analyst Frank Takkinen maintains AVITA Medical (NASDAQ:RCEL) with a Hold and raises the price target from $3 to $3.5.
-
9 months ago benzinga.com
D. Boral Capital Maintains Buy on AVITA Medical, Lowers Price Target to $10
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and lowers the price target from $14 to $10.
-
9 months ago benzinga.com
AVITA Medical Reports FY25 Revenue Of $71.6M, Q4 Revenue Of $17.6M; Sees FY26 Revenue Of $80M-$85M
AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced unaudited preliminary financial results and a…
11 months ago benzinga.com
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
12 months ago benzinga.com
Earnings Scheduled For November 6, 2025
Earnings Scheduled For November 6, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
1 year ago benzinga.com
This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
-
1 year ago benzinga.com
Lake Street Downgrades AVITA Medical to Hold, Lowers Price Target to $4
Lake Street analyst Frank Takkinen downgrades AVITA Medical (NASDAQ:RCEL) from Buy to Hold and lowers the price target from $8 to $4.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
D. Boral Capital Maintains Buy on AVITA Medical, Maintains $14 Price Target
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $14 price target.
-
1 year ago benzinga.com
Reported Earlier, AVITA Medical Announces Leadership Transition With Cary Vance As Interim CEO And Preliminary Q3 Revenue Of $17M
Board Chairman Cary Vance appointed Interim CEOBoard member Jan Stern Reed appointed Lead Independent DirectorThird quarter 2025 preliminary revenue expected to be approximately $17 million
-
1 year ago benzinga.com
AVITA Medical's RECELL Eligible For Up To $4,875 In CMS Reimbursement For Acute Trauma And Surgical Wounds
Hospitals may receive up to $4,875 in added reimbursement when using RECELL to treat non-burn full-thickness acute wounds resulting from trauma or surgeryEffective October 1, the add-on payment eases…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
1 year ago benzinga.com
AVITA Medical Receives CE Mark For RECELL GO, Allowing The Co To Commercialize In Europe And In Other Markets That Recognize The CE Mark
AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH))) ("AVITA Medical", or the "Company"), a leading therapeutic acute wound care company, today announced it has received the CE Mark under the European Union…
-
1 year ago benzinga.com
D. Boral Capital Maintains Buy on AVITA Medical, Lowers Price Target to $14
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and lowers the price target from $18 to $14.
-
1 year ago benzinga.com
AVITA Medical Reaffirms RECELL System Reduces Burn Patient LOS By 36%; More Discharged Home Vs. STSG
Analysis of U.S. national burn registry data demonstrates 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL versus traditional skin grafting More than $42,000 per…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
1 year ago benzinga.com
D. Boral Capital Maintains Buy on AVITA Medical, Lowers Price Target to $18
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and lowers the price target from $19 to $18.